{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:42:45Z","timestamp":1788392565827,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The optimal management of synchronous rectal cancer (RC) and prostate cancer (PC) remains unclear. This systematic review evaluates treatment strategies and reports postoperative, oncological, and quality-of-life outcomes in patients treated with curative intent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Following PRISMA guidelines, this systematic review was registered in PROSPERO (CRD42024598049). A search of Ovid MEDLINE, Embase, CENTRAL, and CDSR (inception to February 2025) identified randomised controlled trials and observational studies on synchronous RC and PC. Synchronous disease was defined as diagnosis or treatment initiation within 12 months. Patients with incurable RC were excluded. Treatment strategies and surgical approaches were analysed, with postoperative, oncological, and survival outcomes assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Eight retrospective studies (124 patients) were included. Common treatments included pelvic chemoradiotherapy (CRT) followed by surgery (29%), prostate booster radiotherapy with CRT (24.2%), prostate brachytherapy (8%), and no prostate-directed treatment (11.3%). Surgical approaches included total mesorectal excision (TME) (74.4%), TME with prostatectomy (10.8%), and en-bloc pelvic exenteration (8%). Primary anastomosis was achieved in 61.8%, with 70% requiring a diverting stoma. Anastomotic leaks occurred in 10.8%, and severe complications (grades 3b\u20135) affected 15.4%, with fewer in robotic-assisted surgery (8.3%). R0 resection was achieved in 92.8%, with no difference between robotic and non-robotic groups. Local recurrence and distant metastasis occurred in 5.9% and 27%, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>There is no consistent approach for managing synchronous RC and PC. High-dose prostate radiotherapy may not improve survival and may increase postoperative complications. Robotic-assisted resections may reduce major complications without compromising oncological outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00384-025-04992-w","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:04:39Z","timestamp":1757549079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of the management of synchronous rectal and prostate cancer: a systematic review"],"prefix":"10.1007","volume":"40","author":[{"given":"Ahmed","family":"Nassar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha E.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mootaz","family":"Elhusseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Parnaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"4992_CR1","unstructured":"Cancer Research UK, https:\/\/www.Cancerresearchuk.Org\/Health-Professional\/Cancer-Statistics\/Statistics-by-Cancer-Type\/Bowel-Cancer#:~:text=There%20are%20around%2044%2C100%20new,Cases%20(2017%2D2019). Accessed Nov 2024."},{"key":"4992_CR2","doi-asserted-by":"crossref","unstructured":"Jacobs C, Trotter J, Palta M, Wu Y, Willett C, Lee WR, Czito BG (2019) Multiinstitutional analysis of synchronous prostate and rectosigmoid cancers. J Clin Oncol Conference 37","DOI":"10.1200\/JCO.2019.37.7_suppl.33"},{"issue":"5","key":"4992_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/s0090-4295(01)00943-8","volume":"57","author":"MK Terris","year":"2001","unstructured":"Terris MK, Wren SM (2001) Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings. Urology 57(5):943\u2013945. https:\/\/doi.org\/10.1016\/s0090-4295(01)00943-8","journal-title":"Urology"},{"issue":"3","key":"4992_CR4","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.prro.2011.11.010","volume":"2","author":"HJ Sharp","year":"2012","unstructured":"Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen Q-N, Hoffman KE, McGuire SE, Frank SJ (2012) Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol 2(3):e7\u2013e13. https:\/\/doi.org\/10.1016\/j.prro.2011.11.010","journal-title":"Pract Radiat Oncol"},{"key":"4992_CR5","volume-title":"Rectal Cancer","author":"S Lotfollahzadeh","year":"2025","unstructured":"Lotfollahzadeh S, Kashyap S, Tsoris A, Recio-Boiles A, Babiker HM (2025) Rectal Cancer. In StatPearls; StatPearls Publishing, Treasure Island (FL)"},{"key":"4992_CR6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2340\/1651-226X.2025.42592","volume":"64","author":"E Edfelt","year":"2025","unstructured":"Edfelt E, Shahrivar M, Holmsten K, Radkiewicz C (2025) Rising Incidence trends of synchronous prostate and rectal cancers: a population-based study. Acta Oncol 64:374\u2013379. https:\/\/doi.org\/10.2340\/1651-226X.2025.42592","journal-title":"Acta Oncol"},{"key":"4992_CR7","doi-asserted-by":"publisher","unstructured":"Briere R, Martin AG, Letarte F, Fournier FR, Bouchard P, Drolet S (2024) Surgical management of rectal cancer with synchronous treatment of prostate cancer. Langenbeck\u2019s Arch Surg 409. https:\/\/doi.org\/10.1007\/s00423-024-03327-7","DOI":"10.1007\/s00423-024-03327-7"},{"key":"4992_CR8","doi-asserted-by":"publisher","unstructured":"Wu V, Sidiqi B, Kobritz M, Purchla J, Herman JM, La Gamma NA, Whelan RL, King D (2022) Synchronous prostate and rectal cancers across a large distributed healthcare system: implications for national accreditation program for rectal cancer (NAPRC) guidelines. J Clin Oncol Conf Annual Meeting Am Soc Clin Oncol ASCO 40(16). https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.e15591","DOI":"10.1200\/JCO.2022.40.16_suppl.e15591"},{"key":"4992_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/ases.13048","volume":"15","author":"K Fukata","year":"2022","unstructured":"Fukata K, Akiyoshi T, Numao N, Komai Y, Mukai T, Hiyoshi Y, Yamaguchi T, Nagasaki T, Konishi T, Fukunaga Y (2022) Robotic-assisted laparoscopic surgery for synchronous primary rectal and prostate cancer: initial case series. Asian J Endoscopic Surg 15:678\u2013682. https:\/\/doi.org\/10.1111\/ases.13048","journal-title":"Asian J Endoscopic Surg"},{"key":"4992_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Joanne ME, BossuytPatrick MM, Boutron I, Hoffmann T, Mulrow CD, Shamseer L, Tetzlaff J, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder E, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch V, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed) 372:71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ (Clin Res Ed)"},{"issue":"2","key":"4992_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santiba\u00f1es E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The clavien-dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187\u2013196. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"4992_CR12","doi-asserted-by":"publisher","unstructured":"Gewanter RM, Sandhu JS, Tin AL, Gross JP, Mazzarella K, Urban J, Elsebai N, Hopkins MF, Vickers AJ, Zelefsky MJ (2023) Assessment of patients with prostate cancer and their understanding of the international prostate symptom score questionnaire. Adv Radiation Oncol 8(4). https:\/\/doi.org\/10.1016\/j.adro.2023.101200","DOI":"10.1016\/j.adro.2023.101200"},{"issue":"3","key":"4992_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3):176\u2013181. https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"4992_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12874-017-0391-8","volume":"17","author":"T Mathes","year":"2017","unstructured":"Mathes T, Pieper D (2017) Clarifying the distinction between case series and cohort studies in systematic reviews of comparative studies: potential impact on body of evidence and workload. BMC Med Res Methodol 17(1):107. https:\/\/doi.org\/10.1186\/s12874-017-0391-8","journal-title":"BMC Med Res Methodol"},{"key":"4992_CR15","unstructured":"(2020) JBI manual for evidence synthesis. JBI"},{"key":"4992_CR16","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1245\/s10434-020-08683-4","volume":"27","author":"A Doussot","year":"2020","unstructured":"Doussot A, Vernerey D, Rullier E, Lefevre JH, Meillat H, Cotte E, Piessen G, Tuech JJ, Panis Y, Mege D, Meurisse A, De Bari B, Heyd B, Lakkis Z (2020) Surgical management and outcomes of rectal cancer with synchronous prostate cancer: a multicenter experience from the GRECCAR group. Ann Surg Oncol 27:4286\u20134293. https:\/\/doi.org\/10.1245\/s10434-020-08683-4","journal-title":"Ann Surg Oncol"},{"key":"4992_CR17","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00384-012-1465-z","volume":"27","author":"DO Kavanagh","year":"2012","unstructured":"Kavanagh DO, Quinlan DM, Armstrong JG, Hyland JMP, O\u2019Connell PR, Winter DC (2012) Management of synchronous rectal and prostate cancer. Int J Colorectal Dis 27:1501\u20131508. https:\/\/doi.org\/10.1007\/s00384-012-1465-z","journal-title":"Int J Colorectal Dis"},{"key":"4992_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/ases.12961","volume":"15","author":"A Maeda","year":"2022","unstructured":"Maeda A, Takahashi H, Watanabe K, Yanagita T, Suzuki T, Nakai N, Maeda Y, Shiga K, Hirokawa T, Ogawa R, Hara M, Matsuo Y, Takiguchi S (2022) The clinical impact of robot-assisted laparoscopic rectal cancer surgery associated with robot-assisted radical prostatectomy. Asian J Endoscopic Surg 15:36\u201343. https:\/\/doi.org\/10.1111\/ases.12961","journal-title":"Asian J Endoscopic Surg"},{"key":"4992_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4111\/icu.20200176","volume":"62","author":"M Williams","year":"2021","unstructured":"Williams M, Perera M, Nouhaud FX, Coughlin G (2021) Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Investigative Clin Urol 62:111\u2013120. https:\/\/doi.org\/10.4111\/icu.20200176","journal-title":"Investigative Clin Urol"},{"key":"4992_CR20","doi-asserted-by":"publisher","unstructured":"Lavan NA, Kavanagh DO, Martin J, Small C, Joyce MR, Faul CM, Kelly PJ, O\u2019Riordain M, Gillham CM, Armstrong JG, Salib O, McNamara DA, McVey G, O\u2019Neill BDP (2016) The curative management of synchronous rectal and prostate cancer. British J Radiol 89. https:\/\/doi.org\/10.1259\/bjr.20150292","DOI":"10.1259\/bjr.20150292"},{"issue":"6","key":"4992_CR21","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ijc.29894","volume":"138","author":"CK Zhou","year":"2016","unstructured":"Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, Bray F, Cook MB, Devesa SS (2016) Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer 138(6):1388\u20131400. https:\/\/doi.org\/10.1002\/ijc.29894","journal-title":"Int J Cancer"},{"issue":"2","key":"4992_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N, Bray F (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72(2):338. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"issue":"1","key":"4992_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2025","unstructured":"Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, Cao Y, Bray F, Jemal A (2025) Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol 26(1):51\u201363. https:\/\/doi.org\/10.1016\/S1470-2045(24)00600-4","journal-title":"Lancet Oncol"},{"issue":"6","key":"4992_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrurol.2014.91","volume":"11","author":"CA Salinas","year":"2014","unstructured":"Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA (2014) Prostate cancer in young men: an important clinical entity. Nat Rev Urol 11(6):317\u2013323. https:\/\/doi.org\/10.1038\/nrurol.2014.91","journal-title":"Nat Rev Urol"},{"key":"4992_CR25","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.26633\/RPSP.2021.114","volume":"45","author":"R Martinez","year":"2021","unstructured":"Martinez R, Morsch P, Soliz P, Hommes C, Ordunez P, Vega E (2021) Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990\u20132019: a population-based study. Rev Panam Salud Publica 45:e114. https:\/\/doi.org\/10.26633\/RPSP.2021.114","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"4992_CR26","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.clon.2013.11.016","volume":"26","author":"R Mir","year":"2014","unstructured":"Mir R, Larbi E, Beveridge S, Khaksar S (2014) What factors contribute to late rectal toxicity after prostate radiotherapy. Clin Oncol 26(2):e6. https:\/\/doi.org\/10.1016\/j.clon.2013.11.016","journal-title":"Clin Oncol"},{"issue":"6","key":"4992_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.ejso.2021.12.472","volume":"48","author":"CK Pleth Nielsen","year":"2022","unstructured":"Pleth Nielsen CK, S\u00f8rensen MM, Christensen HK, Funder JA (2022) Complications and survival after total pelvic exenteration. European J Surg Oncol 48(6):1362\u20131367. https:\/\/doi.org\/10.1016\/j.ejso.2021.12.472","journal-title":"European J Surg Oncol"},{"issue":"5","key":"4992_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3892\/ol.2020.12013","volume":"20","author":"M Yasui","year":"2020","unstructured":"Yasui M, Sakaguchi M, Jikuya R, Tsutsumi S, Tatenuma T, Noguchi G, Umemoto S, Katayama K, Narimatsu H, Uemura H, Kishida T (2020) Comparative effectiveness of surgery and radiotherapy for survival of patients with clinically localized prostate cancer: a population-based coarsened exact matching retrospective cohort study. Oncol Lett 20(5):150. https:\/\/doi.org\/10.3892\/ol.2020.12013","journal-title":"Oncol Lett"},{"issue":"33","key":"4992_CR29","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.3748\/wjg.v25.i33.4850","volume":"25","author":"G Feeney","year":"2019","unstructured":"Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, Kerin M (2019) Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol 25(33):4850\u20134869. https:\/\/doi.org\/10.3748\/wjg.v25.i33.4850","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4992_CR30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ijrobp.2015.03.021","volume":"92","author":"VA Harris","year":"2015","unstructured":"Harris VA, Staffurth J, Naismith O, Esmail A, Gulliford S, Khoo V, Lewis R, Littler J, McNair H, Sadoyze A, Scrase C, Sohaib A, Syndikus I, Zarkar A, Hall E, Dearnaley D (2015) Consensus guidelines and contouring atlas for pelvic node delineation in prostate and pelvic node intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 92(4):874\u2013883. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4992_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.radonc.2016.07.017","volume":"120","author":"V Valentini","year":"2016","unstructured":"Valentini V, Gambacorta MA, Barbaro B, Chiloiro G, Coco C, Das P, Fanfani F, Joye I, Kachnic L, Maingon P, Marijnen C, Ngan S, Haustermans K (2016) International consensus guidelines on clinical target volume delineation in rectal cancer. Radiother Oncol 120(2):195\u2013201. https:\/\/doi.org\/10.1016\/j.radonc.2016.07.017","journal-title":"Radiother Oncol"},{"issue":"8","key":"4992_CR32","doi-asserted-by":"publisher","first-page":"e201625","DOI":"10.1001\/jamasurg.2020.1625","volume":"155","author":"S Biondo","year":"2020","unstructured":"Biondo S, Trenti L, Espin E, Bianco F, Barrios O, Falato A, De Franciscis S, Solis A, Kreisler E (2020) Two-stage turnbull-cutait pull-through coloanal anastomosis for low rectal cancer: a randomized clinical trial. JAMA Surg 155(8):e201625. https:\/\/doi.org\/10.1001\/jamasurg.2020.1625","journal-title":"JAMA Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04992-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-04992-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-04992-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:04:42Z","timestamp":1757549082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-04992-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4992"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-04992-w","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"195"}}